Bacterial derived proteoliposome as ideal delivery system and cellular adjuvant

Vaccine

Volumn 24, Issue SUPPL. 2, 2006, Pages S24-

  Rodríguez, Tamara ^a   Pérez, Oliver ^a   Ugrinovic, Sanja ^b   Bracho, Gustavo ^a   Mastroeni, Pietro ^b  

^a FINLAY INSTITUTE   (Cuba)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Adjuvant; Delivery system; Dendritic cells; Proteoliposome

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; DENDRITIC CELL VACCINE; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OVALBUMIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTATION; ARTICLE; BACTERIAL MEMBRANE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HYBRIDOMA; IMMUNOPOTENTIATION; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; PROTEOLIPOSOME; UPREGULATION;

EID: 33645236033     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.01.106     Document Type: Article

References (2)

1. D.T. O'Hagan, and N.M. Valiante Recent advances in the discovery and delivery of vaccine adjuvants Nature 2 2003 727 735
2. Campa C, Sierra VG, Gutiérrez MM, Biset G, García LG, Puentes G, et al. Method of producing Neisseria meningitidis B vaccine, and vaccine produced by method. US Patent 5,597,572; January 1997.